Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

50.04
-1.7200-3.32%
Pre-market: 50.720.6800+1.36%06:29 EDT
Volume:5.35M
Turnover:270.64M
Market Cap:101.22B
PE:13.39
High:51.67
Open:51.38
Low:50.01
Close:51.76
52wk High:61.70
52wk Low:36.34
Shares:2.02B
Float Shares:1.95B
Volume Ratio:1.17
T/O Rate:0.27%
Dividend:1.75
Dividend Rate:3.50%
EPS(TTM):3.74
EPS(LYR):3.74
ROE:40.91%
ROA:10.02%
PB:4.22
PE(LYR):13.39

Loading ...

SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE

Deep News
·
Jul 09

Alector Ends GSK Collaboration, Retires Hercules Capital Debt

TIPRANKS
·
Jul 09

GSK’s New RSV/hMPV Vaccine Trial Adds Momentum to Its Respiratory Portfolio

TIPRANKS
·
Jul 09

GSK Targets Pediatric Vaccine Growth With New Phase 3 Trial Against Merck’s ProQuad

TIPRANKS
·
Jul 09

GSK Advances Novel Malaria Drug Into Phase 2A, Signaling Long-Term Global Health Upside

TIPRANKS
·
Jul 09

GSK Advances New Malaria Drug With Completed First-in-Human Study

TIPRANKS
·
Jul 09

Dow Jones Top Company Headlines at 7 am ET: Apple to Spend $30 Billion on U.s.-made Chips from Broadcom | Trump-backed ...

Dow Jones
·
Jul 08

GSK, Sino Biopharmaceutical Unit Expand Collaboration to Cover Two GSK Respiratory Therapies

MT Newswires Live
·
Jul 08

Barclays Remains a Sell on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 08

Dow Jones Top Company Headlines at 3 am ET: Sino Biopharm Strikes Drug Licensing Deal with Astrazeneca, Deepens GSK Partnership | White ...

Dow Jones
·
Jul 08

Sino Biopharm Deepens GSK Respiratory Deal to Cement China Lead

TIPRANKS
·
Jul 08

GSK’s StrateGIST Frontline Trial Puts New Cancer Drug Velzatinib in the Spotlight

TIPRANKS
·
Jul 08

Drug Pricing Pressure Puts GSK And Global Pharma Stocks In Focus

Simply Wall St.
·
Jul 07

GSK Falls Monday, Underperforms Market

Dow Jones
·
Jul 07

Pharmaceutical Sector Attracts Capital Rotation, GlaxoSmithKline Surges Nearly 5%

Stock News
·
Jul 02

Movement Alert|GSK Rises 3.02% in Regular Trading, Pharma Sector Rallies as Nuvalent Tender Offer Advances

Market Focus
·
Jul 02

GSK Slides Wednesday, Underperforms Market

Dow Jones
·
Jul 02

GSK’s New mRNA Combo Shot Targets Flu and COVID-19 in One Vaccine

TIPRANKS
·
Jul 01

GSK: Neutral Stance Maintained as Near-Term Strength Offsets Pipeline and Litigation Risks; Price Target Held at £2,350

TIPRANKS
·
Jun 30

Goldman Sachs Sticks to Their Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 30